24
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Biological Markers and Occupational Lung Disease: Mineral Dust-Induced Respiratory Disorders

Pages 457-470 | Received 16 Feb 1994, Published online: 02 Jul 2009

References

  • Cullen M R, Cherniack M G, Rosenstock L. Medical progress: occupational medicine. N Engl J Med 1990; 322: 594–683
  • Weill H. Future of research into occupational lung disease. Brit J Ind Med. 1993; 50: 481–483
  • Nemery B, Van Kerckhoven W, Verbeken E K, Dinsdale D, Demedts M. An unexpected risk of pneumoconiosis in breweries. Proceedings, 8th Int Conf on Occupational Lung diseases, J Hurych, M Lesage, A David. ILO-Geneva and Czech medical Soc-Prague, 1992; Vol II: 658–663
  • National Research Council. Biological markers in environmental health research. Environ Health Persp. 1987; 74: 1–191
  • Schulte P. A conceptual framework for the validation and use of biological markers. Environ Res 1989; 48: 129–144
  • Fowle J R, Sexton K. EPA Priorities for biological markers research in environmental health. Environ Health Persp 1992; 98: 235–241
  • Perera F. Molecular epidemiology: a novel approach to the investigation of pollutant-related chronic disease. Environmental Impacts on Human Health: The Agenda for Long-Term Research and Development, S Draggan, J J Cohrssen, R C Morrison. Praeger, New York 1987; 61–88
  • Wouters E FM, Jorna T HJM, Westenend M. Respiratory effects of coal dust exposure: clinical effects and diagnosis. Exp Lung Res 1994; 20: 385–394
  • Morrow P E. Dust overloading of the lungs: update and appraisal. Toxicol Appl Pharmacol 1992; 113: 1–12
  • Kamp D W, Graceffa B, Pryor W A, Weitzman S A. The role of free radicals in asbestos induced diseases. Free Radical Biol Med 1992; 12: 293–315
  • Mossman B T, Bignon J, Corn M, Seaton A, Gee J BL. Asbestos: scientific developments and implications for public policy. Science 1990; 247: 294–301
  • Kelley J. Cytokines of the lung. Am Rev Respir Dis 1990; 141: 765–788
  • Gautrin D, Auburtin G, Alluin F, et al. Recognition and progression of coal workers pneumoconiosis in the colleries of Northern France. Exp Lung Res 1994; 20: 395–410
  • Begin R, Masse S, Sebastien P. Alveolar dust clearance capacity as determinant of individual susceptibility to asbestosis: new experimental observations. Ann Occup Hyg 1989; 33: 279–282
  • Heffner J E, Repine J E. Antioxidants and the lung. The Lung: Scientific Foundations, R G Crystal, J B West, P J Barnes, N S Cherniack, E R Weibel. Raven, New York 1811, in press
  • Mossman B T, Marsh J P. Role of active oxygen species in asbestos-induced cytotoxicity, cell proliferation and carcinogenesis. Cellular and Molecular Aspects of Fiber Carcinogenesis, C C Harris, J F Lechner, B R Brinkley. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 1991; 159–168
  • Janssen Y MW, Borm P JA, Marsh J P, Mossman B T. The role of active oxygen species in lung toxicity induced by mineral fibers and particulates. Environmental Oxidants, J O Nriagu. Wiley, New York 1992; 445–457
  • Janssen Y MW, Marsh J P, Absher M P, et al. Expression of antioxidant enzymes in rat lungs after inhalation of asbestos or silica. J Biol Chem 1992; 267: 10625–10630
  • Bowden D H. Macrophages, dust and pulmonary diseases. Exp Lung Res 1987; 12: 89–107
  • Marsh J P, Mossman B T. Role of asbestos and active oxygen species in activation and expression of ornithine decarboxylase in hamster trancheal epitheal cells. Cancer Res 1991; 51: 167–173
  • Heintz N H, Janssen Y MW, Mossman B T. Persistent induction of c-fos and c-jun protooncogene expression by asbestos. Proc Natl Acad Sci 1993; 90: 3299–3303
  • Bateman E D, Turner-Warwick M, Adelmann-Grill B C. Immunohistochemical study of collagen types in human fetal lung and fibrotic lung disease. Thorax 1981; 36: 645–653
  • Arden M G, Adamson I YR. Collagen synthesis and degradation during the development of asbestos induced pulmonary fibrosis. Exp Lung Res 1992; 18: 9–20
  • Becklake M, Bignon J, Brochard P, Chiappino G, Cavalleri A, Ward Gardner A. Biologic indicators and their clinical significance in persons exposed to mineral fibres. Br J Ind Med 1993; 50: 412–417
  • Low R B, Giancola M S, King T E, Chapitis J, Vacek P, Davis G S. Serum and bronchoalveolar lavage of N-terminal peptide type III procollagen peptides in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1992; 146: 701–706
  • Pohl W R, Thompson A B, Kohn H, et al. Serum procollagen type III peptide levels in subjects with sarcoidosis: 5-year follow-up study. Am Rev Respir Dis 1992; 145: 412–417
  • Dubois C M, Bissonnette E, Rola-Pleczynski M. Asbestos fibers and silica particles stimulate rat alveolar macrophages to release tumor necrosis factor. Am Rev Respir Dis 1989; 139: 1257–1264
  • Driscoll K E, Lindenschmidt R C, Maurer J K, Higgins J M, Ridder G. Pulmonary response to silica or titanium dioxyde: inflammatory cells, alveolar macrophage-derived cytokines, and histopathology. Am J Respir Cell Mol Biol 1990; 2: 381–390
  • Borm P JA, Palmen N, Engelen J JM, Buurman W A. Spontaneous and stimulated release of tumor necrosis factor-alpha (TNF) from blood monocytes of miners with coal workers' pneumoconiosis. Am Rev Respir Dis 1988; 138: 1589–1594
  • Mohr C, Gemsa D, Graebner C, et al. Systemic macrophage stimulation in rats with silicosis: enhanced release of tumor necrosis factor-α from alveolar and peritoneal macrophages. Am J Respir Cell Mol Biol 1991; 5: 395–402
  • Piquet P F, Collart M A, Grau G E, Sappino A P, Vassalli P. Requirement of tumor necrosis factor for development of silica-induced pulmonary fibrosis. Nature 1990; 344: 245–247
  • Borm P JA, Meijers J JM, Swaen G MH. Molecular epidemiology of coal workers' pneumoconiosis: application to risk assessment of oxidant and monokine generation by mineral dusts. Exp Lung Res 1990; 16: 57–71
  • Borm P JA, Bast A, Wouters E FM, Slangen J JM, Swaen G MH, de Boorder T J. Red blood cell antioxidants in healthy elderly subjects versus silicotic patients. Free Radic Res Commun 1987; 3: 117–127
  • Engelen J JM, Borm P JA, van Sprundel M, Leenaerts L. Blood anti-oxidant parameters at different stages in coal workers' pneumoconiosis. Environ Health Perspect 1990; 84: 165–172
  • Janssen Y MW, Engelen J JM, Giancola M S, Low R B, Vacek P, Borm P JA. Serum type III procollagen in coal miners. Exp Lung Res 1992; 19: 1–9
  • Schins R PF, Borm P JA. Serum procollagen type III peptide in coal workers' pneumoconiosis: a five-year follow-up study. Exp Lung Res 1994; 20: 445–455
  • Porcher J M, Oberson D, Viseux N, et al. Evaluation of tumor necrosis factor-α (TNF) as an exposure or risk marker in three French coal mine regions. Exp Lung Res 1994; 20: 433–443
  • Jorna T HJM, Schins R PF, Lenaerts L, Dehaag T JJM, Wouters E FM, Borm P JA. Airflow obstruction and monocyte TNF release in coal workers. Exp Lung Res 1994; 20: 421–431
  • Lamers R JS, Schins R PF, Borm P JA, Wouters E FM, van Engleshoven J MA. Computed tomography of the lungs in coal workers with a normal chest radiograph. Exp Lung Res 1994; 20: 411–419

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.